On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Neutropenia and Cancer Infections

TopicLeading institutions, researchers & key papers

Neutropenia and Cancer Infections is a topic indexed in ScholarIQ from OpenAlex.

What is known about Neutropenia and Cancer Infections?

ScholarIQrecord summary

This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality.

How many works does Neutropenia and Cancer Infections have?

ScholarIQindexed works

Neutropenia and Cancer Infections has 137 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Neutropenia and Cancer Infections?

ScholarIQopenalex

The OpenAlex for Neutropenia and Cancer Infections is on the source record.

What are the most-cited papers on Neutropenia and Cancer Infections?

ScholarIQmost cited works
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, Jamés O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George D. Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee S. Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Antonio C. Wolff
Journal of Clinical Oncology. 20061,645 CitationsOPEN ACCESS
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
Howard Ozer, Jamés O. Armitage, Charles L. Bennett, Jeffrey Crawford, George D. Demetri, Philip A. Pizzo, Charles A. Schiffer, Thomas J. Smith, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Mark R. Somerfield
Journal of Clinical Oncology. 20001,049 Citations
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
Thomas J. Smith, Kari Bohlke, Gary H. Lyman, Kenneth R. Carson, Jeffrey Crawford, Scott J. Cross, John M. Goldberg, James Khatcheressian, Natasha B. Leighl, Cheryl Perkins, George Somlo, James L. Wade, Antoinette J. Wozniak, Jamés O. Armitage
Journal of Clinical Oncology. 2015915 CitationsOPEN ACCESS
Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study
Élie Azoulay, Djamel Mokart, Frédéric Pène, Jérôme Lambert, Achille Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, Louise-Marie Laisne, Antoine Rabbat, Christine Lebert, Pierre Perez, Marine Chaize, Anne Renault, Anne‐Pascale Meert, Dominique Benoît, Rébecca Hamidfar, M. Jourdain, Michaël Darmon, Benoı̂t Schlemmer, Sylvie Chevret, Virginie Lemiale
Journal of Clinical Oncology. 2013654 CitationsOPEN ACCESS
Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia
Richard M. Stone, Deborah Berg, Stephen L. George, Richard K. Dodge, Paolo Alberto Paciucci, Philip Schulman, Edward J. Lee, Joseph O. Moore, Bayard L. Powell, Charles A. Schiffer
New England Journal of Medicine. 1995455 CitationsOPEN ACCESS

Where is Neutropenia and Cancer Infections research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Neutropenia and Cancer Infections is open access?

ScholarIQopen access share
53%OPEN ACCESS
Gold
7%
Green
0%
Hybrid
13%
Bronze
33%
Closed
47%

Related on ScholarIQ

470M+ articles · 14-day free trial